PMM2-CDG: Phenotype and genotype in four affected family members
Authors:
- Dora CosentiniDCDora Cosentini
- Flavio FaletraFFFlavio Faletra
- Stefania BiffiStefania Biffi
- Eleonora De MartinoEMEleonora De Martino
- Marco CarrozziMCMarco Carrozzi
- Giovanni Maria SeveriniGSGiovanni Maria Severini
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mild Clinical and Biochemical Phenotype in Two Patients with PMM2-CDG (Congenital Disorder of Glycosylation Ia)The Cerebellum, 2011
- The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Clinical phenotype correlates to glycoprotein phenotype in a sib pair with CDG‐IaAmerican Journal of Medical Genetics Part A, 2008
- Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs)Clinical Biochemistry, 2007
- Congenital disorder of glycosylation type 1a: Three siblings with a mild neurological phenotypeJournal of Clinical Neuroscience, 2007
- HPLC analysis of carbohydrate deficient transferrin isoforms isolated by the Axis-Shield %CDT methodClinica Chimica Acta, 2005
- Underdiagnosis of mild congenital disorders of glycosylation type IaPediatric Neurology, 2004
- High Residual Activity of PMM2 in Patients’ Fibroblasts: Possible Pitfall in the Diagnosis of CDG-Ia (Phosphomannomutase Deficiency)The American Journal of Human Genetics, 2001
- Personal Experience with the Application of Carbohydrate-Deficient Transferrin (CDT) Assays to the Detection of Congenital Disorders of GlycosylationClinical Chemistry and Laboratory Medicine (CCLM), 2000
- Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesisAnnals of Neurology, 2000